| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,756 |
14,422 |
$1.47M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,150 |
1,930 |
$139K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,565 |
2,273 |
$51K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
362 |
355 |
$46K |
| 99215 |
Prolong outpt/office vis |
505 |
467 |
$43K |
| 36415 |
Collection of venous blood by venipuncture |
6,036 |
5,964 |
$30K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
270 |
265 |
$24K |
| 99442 |
|
211 |
200 |
$21K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
88 |
13 |
$18K |
| 95923 |
|
329 |
303 |
$16K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
148 |
148 |
$16K |
| 80061 |
Lipid panel |
1,200 |
1,189 |
$15K |
| 99443 |
|
116 |
97 |
$13K |
| 93922 |
|
317 |
294 |
$13K |
| 95921 |
|
392 |
363 |
$12K |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
1,046 |
935 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,073 |
1,066 |
$10K |
| 87428 |
|
153 |
140 |
$10K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
473 |
465 |
$10K |
| 96130 |
|
54 |
53 |
$8K |
| 90686 |
|
389 |
381 |
$7K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
36 |
36 |
$4K |
| 82947 |
|
983 |
978 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
415 |
415 |
$3K |
| 93923 |
|
32 |
29 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,296 |
1,181 |
$2K |
| 93000 |
|
184 |
172 |
$2K |
| 81002 |
|
738 |
696 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
111 |
109 |
$2K |
| 96138 |
|
54 |
53 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
198 |
162 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
36 |
34 |
$1K |
| 93970 |
|
12 |
12 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
196 |
163 |
$914.17 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
436 |
397 |
$709.72 |
| 90658 |
|
47 |
46 |
$485.86 |
| 96127 |
|
14 |
14 |
$384.44 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
73 |
69 |
$357.85 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$170.94 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
14 |
14 |
$152.86 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
14 |
13 |
$87.79 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$33.56 |
| Q2035 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
13 |
13 |
$18.24 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
99 |
71 |
$2.93 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
64 |
52 |
$1.76 |
| 99606 |
|
237 |
210 |
$0.12 |
| 1160F |
|
196 |
177 |
$0.00 |
| 3077F |
|
62 |
57 |
$0.00 |
| 3078F |
|
1,092 |
974 |
$0.00 |
| 1159F |
|
103 |
96 |
$0.00 |
| 3074F |
|
907 |
813 |
$0.00 |
| 1170F |
|
14 |
14 |
$0.00 |
| 1125F |
|
27 |
26 |
$0.00 |
| 3075F |
|
18 |
15 |
$0.00 |